{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:31:31Z","timestamp":1787229091955,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03316-8","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:22:07Z","timestamp":1787228527000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cardiometabolic perspective on post-exertional malaise in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) and Long COVID"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4476-4198","authenticated-orcid":false,"given":"Francisco","family":"Westermeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9108-2384","authenticated-orcid":false,"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1963-499X","authenticated-orcid":false,"given":"Eva","family":"Untersmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0929-133X","authenticated-orcid":false,"given":"Romina","family":"Bertinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-1706","authenticated-orcid":false,"given":"Nuno","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7055-4488","authenticated-orcid":false,"given":"Enrique","family":"Fisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"3316_CR1","doi-asserted-by":"publisher","unstructured":"Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. Integrative Biology of Exercise. Cell. 2014;159:738\u201349. https:\/\/doi.org\/10.1016\/j.cell.2014.10.029.","DOI":"10.1016\/j.cell.2014.10.029"},{"key":"3316_CR2","doi-asserted-by":"publisher","unstructured":"McGee SL, Hargreaves M. Exercise adaptations: molecular mechanisms and potential targets for therapeutic benefit. Nat Rev Endocrinol. 2020;16:495\u2013505. https:\/\/doi.org\/10.1038\/s41574-020-0377-1.","DOI":"10.1038\/s41574-020-0377-1"},{"key":"3316_CR3","doi-asserted-by":"publisher","unstructured":"Contrepois K, Wu S, Moneghetti KJ, Hornburg D, Ahadi S, Tsai M-S, et al. Molecular Choreography of Acute Exercise. Cell. 2020;181:1112\u2013e113016. https:\/\/doi.org\/10.1016\/j.cell.2020.04.043.","DOI":"10.1016\/j.cell.2020.04.043"},{"key":"3316_CR4","doi-asserted-by":"publisher","unstructured":"Noone J, Mucinski JM, DeLany JP, Sparks LM, Goodpaster BH. Understanding the variation in exercise responses to guide personalized physical activity prescriptions. Cell Metab. 2024;36:702\u201324. https:\/\/doi.org\/10.1016\/j.cmet.2023.12.025.","DOI":"10.1016\/j.cmet.2023.12.025"},{"key":"3316_CR5","doi-asserted-by":"publisher","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022;28:911\u201323. https:\/\/doi.org\/10.1038\/s41591-022-01810-6.","DOI":"10.1038\/s41591-022-01810-6"},{"key":"3316_CR6","doi-asserted-by":"publisher","unstructured":"Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. Mayo Clin Proc [Internet]. 2021;96:2861\u201378. https:\/\/doi.org\/10.1016\/j.mayocp.2021.07.004.","DOI":"10.1016\/j.mayocp.2021.07.004"},{"key":"3316_CR7","doi-asserted-by":"publisher","unstructured":"Davis HE, McCorkell L, Vogel JM, Topol EJ, Long COVID. major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133\u201346. https:\/\/doi.org\/10.1038\/s41579-022-00846-2.","DOI":"10.1038\/s41579-022-00846-2"},{"key":"3316_CR8","doi-asserted-by":"publisher","unstructured":"Faghy MA, W\u00fcst RCI, Altmann DM, Ashton RE, McMullen SB, Duncan R, et al. Current status and future perspectives on the mechanistic and pathophysiological understanding of long COVID. Commun Med. 2026;6:255. https:\/\/doi.org\/10.1038\/s43856-025-01300-z.","DOI":"10.1038\/s43856-025-01300-z"},{"key":"3316_CR9","doi-asserted-by":"publisher","unstructured":"Komaroff AL, Lipkin WI. ME\/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne). 2023;10. https:\/\/doi.org\/10.3389\/fmed.2023.1187163.","DOI":"10.3389\/fmed.2023.1187163"},{"key":"3316_CR10","doi-asserted-by":"publisher","unstructured":"Haunhorst S, Dudziak D, Scheibenbogen C, Seifert M, Sotzny F, Finke C, et al. Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis\/chronic fatigue syndrome. Infection. 2025;53:1\u201313. https:\/\/doi.org\/10.1007\/s15010-024-02386-8.","DOI":"10.1007\/s15010-024-02386-8"},{"key":"3316_CR11","doi-asserted-by":"publisher","unstructured":"Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: the biology of a neglected disease. Front Immunol. 2024;15. https:\/\/doi.org\/10.3389\/fimmu.2024.1386607.","DOI":"10.3389\/fimmu.2024.1386607"},{"key":"3316_CR12","doi-asserted-by":"publisher","unstructured":"Grabowska AD, Westermeier F, Nacul L, Lacerda E, Sep\u00falveda N. The importance of estimating prevalence of ME\/CFS in future epidemiological studies of long COVID. Front Public Health. 2023;11. https:\/\/doi.org\/10.3389\/fpubh.2023.1275827.","DOI":"10.3389\/fpubh.2023.1275827"},{"key":"3316_CR13","doi-asserted-by":"publisher","unstructured":"Soares L, Davis H, Spier E, Walker T, Davenport T, Putrino D, et al. Recommended long COVID outcome measures and their implications for clinical trial design, with a focus on post-exertional malaise. EBioMedicine. 2026;123:106083. https:\/\/doi.org\/10.1016\/j.ebiom.2025.106083.","DOI":"10.1016\/j.ebiom.2025.106083"},{"key":"3316_CR14","doi-asserted-by":"publisher","unstructured":"Hofmann L, Jeremic D, Le\u00f3n LE, Pipper-Krampl C, Pfurtscheller D, Seifert M, et al. Sex-related cardiometabolic differences in ME\/CFS patients. Heliyon. 2025;11:e43903. https:\/\/doi.org\/10.1016\/j.heliyon.2025.e43903.","DOI":"10.1016\/j.heliyon.2025.e43903"},{"key":"3316_CR15","doi-asserted-by":"publisher","unstructured":"Stussman B, Camarillo N, McCrossin G, Stockman M, Norato G, Vetter CS, et al. Post-exertional malaise in Long COVID: subjective reporting versus objective assessment. Front Neurol. 2025;16. https:\/\/doi.org\/10.3389\/fneur.2025.1534352.","DOI":"10.3389\/fneur.2025.1534352"},{"key":"3316_CR16","doi-asserted-by":"publisher","unstructured":"van Campen C (Linda), Rowe MC, Visser PC FC, editors. Validation of the Severity of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome by Other Measures than History: Activity Bracelet, Cardiopulmonary Exercise Testing and a Validated Activity Questionnaire: SF-36. Healthcare. 2020;8:273. https:\/\/doi.org\/10.3390\/healthcare8030273","DOI":"10.3390\/healthcare8030273"},{"key":"3316_CR17","doi-asserted-by":"publisher","unstructured":"Nacul LC, Mudie K, Kingdon CC, Clark TG, Lacerda EM. Hand Grip Strength as a Clinical Biomarker for ME\/CFS and Disease Severity. Front Neurol. 2018;9. https:\/\/doi.org\/10.3389\/fneur.2018.00992.","DOI":"10.3389\/fneur.2018.00992"},{"key":"3316_CR18","doi-asserted-by":"publisher","unstructured":"van Campen C (Linda), Rowe MC, Visser PC FC, editors. Worsening Symptoms Is Associated with Larger Cerebral Blood Flow Abnormalities during Tilt-Testing in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS). Medicina (B Aires). 2023;59:2153. https:\/\/doi.org\/10.3390\/medicina59122153","DOI":"10.3390\/medicina59122153"},{"key":"3316_CR19","doi-asserted-by":"publisher","unstructured":"van Campen C (Linda), Visser MC FC, editors. Orthostatic Intolerance in Long-Haul COVID after SARS-CoV-2: A Case-Control Comparison with Post-EBV and Insidious-Onset Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Patients. Healthcare. 2022;10:2058. https:\/\/doi.org\/10.3390\/healthcare10102058","DOI":"10.3390\/healthcare10102058"},{"key":"3316_CR20","doi-asserted-by":"publisher","unstructured":"Conroy K, Bhatia S, Islam M, Jason LA. Homebound versus Bedridden Status among Those with Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Healthcare. 2021;9:106. https:\/\/doi.org\/10.3390\/healthcare9020106.","DOI":"10.3390\/healthcare9020106"},{"key":"3316_CR21","doi-asserted-by":"publisher","unstructured":"Institute of Medicine. Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness. Washington, D.C.: National Academies; 2015. https:\/\/doi.org\/10.17226\/19012.","DOI":"10.17226\/19012"},{"key":"3316_CR22","doi-asserted-by":"publisher","unstructured":"Gabriel BM, Zierath JR. The Limits of Exercise Physiology: From Performance to Health. Cell Metab. 2017;25:1000\u201311. https:\/\/doi.org\/10.1016\/j.cmet.2017.04.018.","DOI":"10.1016\/j.cmet.2017.04.018"},{"key":"3316_CR23","doi-asserted-by":"publisher","unstructured":"Phelps CM, Meisel M. The immunology of exercise: Mechanisms, mediators, and therapeutic opportunities. Immunity. 2026. https:\/\/doi.org\/10.1016\/j.immuni.2026.04.016.","DOI":"10.1016\/j.immuni.2026.04.016"},{"key":"3316_CR24","doi-asserted-by":"publisher","unstructured":"Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome. Front Pediatr. 2018;6. https:\/\/doi.org\/10.3389\/fped.2018.00242.","DOI":"10.3389\/fped.2018.00242"},{"key":"3316_CR25","doi-asserted-by":"publisher","unstructured":"Lim E-J, Kang E-B, Jang E-S, Son C-G. The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME\/CFS Patients: A Meta-Analysis. J Clin Med. 2020;9:4040. https:\/\/doi.org\/10.3390\/jcm9124040.","DOI":"10.3390\/jcm9124040"},{"key":"3316_CR26","doi-asserted-by":"publisher","unstructured":"Nunes JM, Kell DB, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): A role for viruses. Blood Rev. 2023;60:101075. https:\/\/doi.org\/10.1016\/j.blre.2023.101075.","DOI":"10.1016\/j.blre.2023.101075"},{"key":"3316_CR27","doi-asserted-by":"publisher","unstructured":"Wirth KJ, L\u00f6hn M. Microvascular Capillary and Precapillary Cardiovascular Disturbances Strongly Interact to Severely Affect Tissue Perfusion and Mitochondrial Function in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Evolving from the Post COVID-19 Syndrome. Med (B Aires). 2024;60:194. https:\/\/doi.org\/10.3390\/medicina60020194.","DOI":"10.3390\/medicina60020194"},{"key":"3316_CR28","doi-asserted-by":"publisher","unstructured":"Kvitkina T, Narres M, Andrich S, Wilm S, Icks A, Claessen H. Incidence, risk factors and sequelae of long\/post-COVID in people with diabetes compared to people without diabetes in Germany (longcovid-diab): a study protocol. Cardiovasc Diabetol. 2026;25:165. https:\/\/doi.org\/10.1186\/s12933-026-03222-z.","DOI":"10.1186\/s12933-026-03222-z"},{"key":"3316_CR29","doi-asserted-by":"publisher","unstructured":"Ruhrl\u00e4nder J, Schieffer E, Schieffer B. Regulatory cycles of orexin and glucagon-Like peptide-1 in postviral syndromes. Endocr Rev. 2026. https:\/\/doi.org\/10.1210\/endrev\/bnag009.","DOI":"10.1210\/endrev\/bnag009"},{"key":"3316_CR30","doi-asserted-by":"publisher","unstructured":"Fineberg D, Moreau A, Schneider-Futschik EK, Armstrong CW. A Perspective on the Role of Metformin in Treating Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) and Long COVID. ACS Pharmacol Transl Sci. 2025;8:3411\u201331. https:\/\/doi.org\/10.1021\/acsptsci.5c00229.","DOI":"10.1021\/acsptsci.5c00229"},{"key":"3316_CR31","doi-asserted-by":"publisher","unstructured":"Drucker DJ. The expanding landscape of GLP-1 medicines. Nat Med. 2026;32:47\u201357. https:\/\/doi.org\/10.1038\/s41591-025-04124-5.","DOI":"10.1038\/s41591-025-04124-5"},{"key":"3316_CR32","unstructured":"Foundation for the National Institutes of Health. RECOVER-TLC [Internet]. 2026. https:\/\/fnih.org\/our-programs\/recover-tlc-will-advance-long-covid-research\/recover-tlc-clinical-trials\/."},{"key":"3316_CR33","unstructured":"Scripps Translational Science Institute. The Long COVID Treatment Trial (LOCITT) [Internet]. 2025. https:\/\/clinicaltrials.gov\/study\/NCT07128082."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03316-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03316-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T12:22:10Z","timestamp":1787228530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03316-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3316"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03316-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"21 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"At the time of publication, Enrique Fisman serves as Editor-in-Chief, Francisco Westermeier as Deputy Editor, Nuno Sep\u00falveda as Associate Editor, and Etheresia Pretorius as a member of the Editorial Board of\n                      Cardiovascular Diabetology\n                      . Etheresia Pretorius is the Founding Director of Biocode Technologies and is an inventor on a patent related to the detection of amyloid microclots in Long COVID. The authors declare no additional competing interests related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"250"}}